Catalyst Pharmaceuticals Inc (CPRX)

Quick ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Cash	US$ in thousands	137,636	120,971	178,787	148,247	298,395	256,065	210,912	178,372	171,445	154,836	135,295	127,328	130,237	117,106	115,052	101,751	89,512	44,983	23,418	19,082
Short-term investments	US$ in thousands	0	0	—	—	0	0	9,876	19,424	19,821	19,956	19,980	15,971	10,041	10,003	0	5,007	5,007	31,562	36,503	26,551
Receivables	US$ in thousands	53,514	48,049	42,796	33,402	10,439	9,337	9,587	10,552	6,619	6,625	6,292	5,601	5,987	5,872	6,762	6,919	10,537	10,095	10,376	7,251
Total current liabilities	US$ in thousands	76,063	57,806	52,503	56,709	57,588	44,681	22,488	22,938	27,063	20,614	16,135	14,436	22,756	18,232	20,210	17,636	24,099	17,982	14,152	9,026
Quick ratio		2.51	2.92	4.22	3.20	5.36	5.94	10.24	9.08	7.31	8.80	10.01	10.31	6.43	7.29	6.03	6.45	4.36	4.82	4.97	5.86

December 31, 2023 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($137,636K + $0K + $53,514K) ÷ $76,063K
= 2.51

The quick ratio of Catalyst Pharmaceuticals Inc has shown fluctuations over the past several quarters. The quick ratio measures the company's ability to meet its short-term obligations with its most liquid assets, excluding inventory.

From the data provided, we observe that the quick ratio has generally been above 1, indicating that the company has had an adequate level of liquid assets to cover its current liabilities. The quick ratio has ranged from a high of 10.31 in March 2021 to a low of 2.51 in December 2023.

The trend in the quick ratio shows that Catalyst Pharmaceuticals Inc has maintained a strong liquidity position over the periods analyzed. A high quick ratio suggests that the company has a low level of risk of facing liquidity issues in the near term, as it has a significant amount of liquid assets relative to its current liabilities.

Overall, the quick ratio analysis indicates that Catalyst Pharmaceuticals Inc has had a consistent ability to meet its short-term obligations with its readily available assets, providing a positive signal regarding its financial health. However, it is important to monitor the trend of the quick ratio over time to ensure that the company's liquidity position remains stable and sustainable.